Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials

OBJECTIVES: Osteoporosis remains a clinical challenge. Teriparatide is an anabolic drug and alendronate is an antiresorptive agent; both are used in the treatment of osteoporosis. Comprehensive reviews investigating the comparative safety and efficacy of teriparatide versus alendronate are scarce. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ya-Kang, Qin, Si-Qing, Ma, Tao, Song, Wei, Jiang, Ren-Qi, Guo, Jian-Bin, Li, Kun, Zhang, Yu-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
7400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457876/
https://www.ncbi.nlm.nih.gov/pubmed/28538396
http://dx.doi.org/10.1097/MD.0000000000006970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457876/
https://www.ncbi.nlm.nih.gov/pubmed/28538396
http://dx.doi.org/10.1097/MD.0000000000006970

Ejemplares similares